China vs Netherlands: Leprosy - New leprosy cases with G2D rate per 1 000 000 population
China
0.042
in 2024
Netherlands
0.057
in 2023
China rank
82nd
Netherlands rank
79th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population over time
- China
- Netherlands
How they compare
Netherlands currently reports 0.057 against 0.042 in China, a difference of 0.015.
That makes Netherlands's figure about 1.4 times China's.
The two have swapped places 3 times across 6 shared years of data; in 2016 it was China ahead.
China ranks 82nd and Netherlands ranks 79th of 161 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0879 | 0 | 0.0879 | China |
| 2020s | 0.0503 | 0.039 | 0.0113 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher leprosy - new leprosy cases with g2d rate per 1 000 000 population, China or Netherlands?
- Netherlands, at 0.057 against 0.042 in China as of 2023.
- What is the difference in leprosy - new leprosy cases with g2d rate per 1 000 000 population between China and Netherlands?
- 0.015, with Netherlands ahead.
- How many years of comparable data are there for China and Netherlands?
- 6 years are reported by both, from 2016 to 2023.
- How do China and Netherlands rank globally for leprosy - new leprosy cases with g2d rate per 1 000 000 population?
- China ranks 82nd and Netherlands ranks 79th of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Leprosy - New leprosy cases with G2D rate per 1 000 000 population. Statizoid refreshes it automatically from the source and publishes the full history for both places.